Vaccinex Expands Access to ActivMAb Antigen Virus Technology
ActivMAb's new "Antigen Virus" application complements drug discovery strategies for complex protein targets, according to Vaccinex CEO. Ongoing partnerships can ...
- Latest
- Trending
ActivMAb's new "Antigen Virus" application complements drug discovery strategies for complex protein targets, according to Vaccinex CEO. Ongoing partnerships can ...
Cagent Vascular's series C financing round has raised over $30m, enabling them to expand their product portfolio and accelerate US ...
Mounting inflation and interest rates are putting pressure on the real estate sector. Experts suggest having 10% exposure to real ...
Charlotte City Council has purchased the Budget and Economy Inn in Northwest Charlotte as part of a plan to improve ...
China Medical University Hospital (CMUH) is partnering with Google Cloud to use generative AI for cancer care. The AI can ...
Investors are advised on tomorrow's top stock picks as NVIDIA and Lam Research thrive, while Intel and Gilead Sciences face ...
Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...
Fujitsu has achieved a significant breakthrough in quantum computing speed, with a new technique on a quantum simulator that is ...
An Australian police officer is investigated for allegedly stealing $4M worth of Bitcoin during a drug raid, highlighting the growing ...
Investigation reveals significant delays in processing complaints against UK drug companies, raising concerns about patient safety and public health. Increased ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.